APA (7th ed.) Citation

YD, K., SM, P., HC, H., AR, L., H, W., H, C., . . . JM, C. (2020). HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment. Journal of Cancer, 11(14), 4059. https://doi.org/10.7150/jca.44622

Chicago Style (17th ed.) Citation

YD, Kim, Park SM, Ha HC, Lee AR, Won H, Cha H, Cho S, and Cho JM. "HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment." Journal of Cancer 11, no. 14 (2020): 4059. https://doi.org/10.7150/jca.44622.

MLA (9th ed.) Citation

YD, Kim, et al. "HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment." Journal of Cancer, vol. 11, no. 14, 2020, p. 4059, https://doi.org/10.7150/jca.44622.